CHChristine Hill

Christine Hill

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Christine Hill has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Correction: A systematic review of the frequency of sleep evaluations, sleep disorders, and treatments among individuals with muscular dystrophy

    by Nedra Whitehead, Joyce T. Alese, Christine Hill, Mike Enger, Jamie Zimmerman, Amy Moore, Julie Royer, Swamy Venkatash, Shiny Thomas, Barbara Do, et al.

  • A systematic review of the frequency of sleep evaluations, sleep disorders, and treatments among individuals with muscular dystrophy

    by Nedra Whitehead, Joyce T. Alese, Christine Hill, Mike Enger, Jamie Zimmerman, Amy Moore, Julie Royer, Swamy Venkatash, Shiny Thomas, Barbara Do, et al.

    Purpose Review literature on the frequency of sleep disorders and receipt of sleep-related healthcare among individuals with muscular dystrophy. Methods Included: Population–Duchenne/Becker (DBMD), congenital (CMD), facioscapulohumeral (FSHD), limb-girdle (LGMD), or myotonic (DM) muscular dystrophy; Outcomes–frequency of sleep evaluations, disorders, or treatments; Language–English; Study type–original research, systematic review. Excluded: Sample Information sources: PubMed and EBSCO, last searched March 7, 2023. Risk of bias assessment : Recruitment source or study inclusion selected for or against sleep symptoms or disorders. Synthesis: Range and weighted average (low risk studies only) of outcome. Results We included 95 studies of sleep evaluations (7), disorders (94) or treatments (13) with a total of 7,964 participants. Studies reported on DM–61, DBMD–20, FSHD–9, CMD–1, LGMD–1, and multiple MD–3. One-half of people with DBMD (51%, 2 studies, 85 individuals) and over 60% of people with DM1 (65%, 2 studies, 327 individuals) had a sleep study. Measured by questionnaire, excessive daytime sleepiness frequency among adults with DM was 39% (DM2, 10, 284) to 65% (any DM, 6, 1195), 9% among controls (5, 199), and 6% to 13% among other MDs. Sleep apnea frequency was 11% (LGMD, 1, 18) to 65% (CMD, 1, 20). Assisted ventilation use was 5%–16% (DM). Conclusions Regular sleep evaluations may improve identification and treatment of sleep disorders and the physical and mental health of individuals with MD. Other Funding–US Centers for Disease Control and Prevention. Not registered.